Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool September 28, 2005 Brian Gorman	Monsanto's Rich Pipeline The agrochemical giant's long-term health looks assured thanks to a rich product pipeline. Investors, take note.
BusinessWeek January 21, 2010 Jack Kaskey	Monsanto Will Let Bio-Crop Patents Expire Genetically engineered soybeans will go generic, but woe to anyone that crosses the seed giant on new products.
The Motley Fool September 3, 2008 Brian Orelli	Monsanto's Public-Relations Nightmare Agriculture giant Monsanto has to defend its patents without looking like it's picking on the little guy.
The Motley Fool March 2, 2005 Brian Gorman	Monsanto's Brazil Benefit Brazil is on the cusp of legalizing genetically modified seed sales, a potential boon for Monsanto.
The Motley Fool December 5, 2006 Brian Gorman	Monsanto Needs to Charm The company has to confront concerns over genetically modified foods soon if it hopes to keep growing. Investors, take note.
Chemistry World May 22, 2013 Rebecca Trager	US Supreme Court rules in favour of Monsanto The Supreme Court justices upheld a lower court's ruling that a farmer, Vernon Bowman, violated Monsanto's intellectual property rights by regrowing second-generation seeds.
The Motley Fool December 6, 2011 Neha Chamaria	Debugging Monsanto's Bug Concerns Doubts about Monsanto's pest-resistant seeds' efficiency grow. Should you become cautious?
The Motley Fool August 2, 2007 Brian Orelli	Monsanto Counts Beans Agricultural giant Monsanto is one step closer to launching its new soybean. In field-testing the new seeds have demonstrated a 7%-11% increase in yield.
Chemistry World April 12, 2013 Anbdrew Turley	DuPont and Monsanto settle Roundup dispute Two US chemical heavyweights -- DuPont and agrichemical company Monsanto -- have agreed to drop a long running intellectual property dispute to make way for a series of licensing deals worth at least $1.75 billion.
The Motley Fool January 4, 2007 Brian Gorman	Monsanto's Bigger Harvest? High corn prices could allow Monsanto to raise seed prices and improve margins. Investors, take note.
Inc. June 2006 Athena Schindelheim	Great Moments In Patent History With the blockbuster BlackBerry settlement and a case involving eBay before the Supreme Court, the dowdy world of patent law is suddenly hot.
Registered Rep. April 1, 2006 Bob Hirschfeld	Good Breeding Ag-biotech is entering a period of vibrant growth as farmers, not only in the U.S., but Brazil, India and China increase usage of the highly productive seeds. Is Wall Street valuing shares of ag-biotech companies correctly?
Chemistry World June 4, 2009 Sarah Houlton	Agrochemical firms in patent battle BASF and DuPont are squaring up for a battle over technology that makes plants resistant to commonly used herbicides.
The Motley Fool April 2, 2009 Brian Orelli	Monsanto Rounds Up Alternative Growth Forget Roundup. The agri-giant has a better plan.
The Motley Fool March 31, 2004 W.D. Crotty	Monsanto in the Balance Genetically modified crops are a boon for the company.
The Motley Fool March 29, 2005 Stephen D. Simpson	Monsanto Sows the Seeds of Growth The agricultural specialist hikes earnings guidance on the back of strong sales. The present valuation may look rich, but investors shouldn't underestimate this growing titan.
Chemistry World July 22, 2013 Phillip Broadwith	Monsanto abandons GM crops in Europe The company will focus on conventional breeding to develop new crop varieties in the EU, and develop biotech crops in regions where they are more accepted, such as North America.
The Motley Fool May 19, 2004 Brian Gorman	U.N. Plants Seed for Agribusiness Its endorsement of biotech foods could clear the way for agribusiness in the developing world.
The Motley Fool April 6, 2005 W.D. Crotty	Fast-Blooming Biotech Monsanto's net sales and net income soar in the second quarter. Is it time to buy this stock?
Chemistry World July 8, 2010 Andrew Turley	DNA must do its job for patent protection A European court has ruled that patents for DNA do not give protection when the sequences are no longer performing the task they were inserted to do.
The Motley Fool December 7, 2009 Jordan DiPietro	How Terrible Is Monsanto? Monsanto, the global provider of agricultural products, finds its reputation being slammed in a recent food documentary, Food Inc. Which is Monsanto -- savior or sinner?
The Motley Fool December 6, 2005 Brian Gorman	Monsanto's Trade Dividend The giant and competitors in agricultural biotechnology should enjoy rising sales in the developed world as subsidies come down. Investors, take note.
The Motley Fool March 23, 2006 Alyce Lomax	Monsanto: Monster Stock, or Just Plain Monster? Many things seem to be going right for Monsanto. However, what price are you willing to pay for growth? Are the profits worth the risks -- and the possible long-term ramifications -- for both investors and consumers?
InternetNews March 4, 2010	Microsoft Inks Linux Patent Deal With I-O Fresh off of its Linux licensing agreement with Amazon, Microsoft has dropped word that it's reach a similar patent accord with I-O Data Device, a Japanese hardware firm.
The Motley Fool January 31, 2011 Alyce Lomax	Monsanto: Winner or Sinner? This stock won't show up in my SRI portfolio. Here's why.
The Motley Fool January 25, 2005 Brian Gorman	Monsanto Picks Seminis Monsanto's latest acquisition provides a sensible avenue for growth. Investors apparently are less than thrilled about the deal, because they sent the stock down almost 7% in trading.
InternetNews May 20, 2005 Sean Michael Kerner	A Primer on Software Patents A closer look at software patents and at their history and implications for IT.
The Motley Fool March 23, 2007 Alyce Lomax	Is Monsanto Going to Seed? Several recent news headlines referring to its genetically modified products should give investors some reason to contemplate the risks that face this biotech giant.
The Motley Fool May 11, 2004 Brian Gorman	Monsanto's Fallow Wheat Field Monsanto halts development of its controversial genetically modified spring wheat.
The Motley Fool January 11, 2012 Jacob Roche	Betting the Farm on Monsanto The biotech giant sits at the top of the food chain.
The Motley Fool April 5, 2006 Stephen D. Simpson	This GM Actually Works Monsanto's path may be strewn with weeds, but rewards could still lurk within. This is a good company, and looks to be undervalued by a mid-teens percentage. Investors, take note.
The Motley Fool December 5, 2008 Brian Orelli	Monsanto Ready to Round Up Growth The company announces that the European Union has approved its genetically modified soybean seeds for import.
The Motley Fool September 27, 2004 Brian Gorman	Monsanto Gets Tough The company is getting tough with some South American countries about its pirated technology. All the same, the company will have to maintain a diplomatic posture for its own sake.
The Motley Fool May 27, 2008 Brian Orelli	Super Seed Swap Instead of continuing to fight each other in court, agribusiness companies Syngenta and Monsanto called a truce for their never-ending patent disputes last week.
Entrepreneur October 2005 Chris Penttila	Patent Pending Have an idea for the next big thing? You'll need a patent, but pay attention to big changes in store for U.S. patent law.
The Motley Fool June 22, 2004 Brian Gorman	More Green for Monsanto The full-year earnings the agribusiness giant Monsanto may not please everyone, but the company plants roots for long-term success.
The Motley Fool April 13, 2006 Brian Gorman	Monsanto's New Challenge The ag-biotech firm faces new competitive pressures from rivals and an ongoing wariness of GM crops in Europe.
CIO August 1, 2003 Mark Radcliffe	Patents: A Small Price to Pay for Progress For CIOs, the issue is not whether patents should be granted for software but whether anything can be done to improve the quality of the granted patents. The problem relates more to the examining process in the USPTO than to the appropriateness of patents for software.
InternetNews April 19, 2007 Michael Hickins	Microsoft, Samsung Cross Bridge Over GPL Microsoft announced today that it has entered into a broad cross-licensing agreement with South Korean electronics maker Samsung.
AskMen.com March 19, 2003 Steve Richer	How To: Patent An Invention Investors will not do business with you until you have that precious little number that guarantees that you own the rights to the invention. Read on to see how you can obtain a patent.
AskMen.com Sebastien Stefanov	Are Modified Foods Dangerous? What foods are potentially dangerous, what are the risks and how can consumers protect themselves against this new industry?
The Motley Fool June 29, 2011 Brian Orelli	Monsanto Is Back From the Dead Roundup makes a triumphant return, but investors should focus on the seed business.
The Motley Fool May 28, 2009 Brian Orelli	Monsanto Plowed Down Low end of guidance is better than lowered guidance, I guess.
IndustryWeek August 1, 2003 John Teresko	Intellectual Property, It's Worth Keeping An Eye On Making sure intellectual property is protected can reap benefits and prevent hassles.
PC Magazine August 29, 2007	Cell Phones That Shouldn't Be Comb through the archives of the U.S. Patent Office and you will find some truly bizarre and hilarious inventions that never made it to the market.
The Motley Fool July 30, 2004 Brian Gorman	In China, Hope for Modified Seeds China leans toward allowing genetically modified crops, a potential windfall for Monsanto and competitors.
CIO January 1, 2003 Christopher Koch	Patently Stupid? It's not clear at the start of 2003 whether the software patent frenzy will cause innovation to flower or be trampled.
Information Today May 2006 George H. Pike	Feature: BlackBerry: Lawsuit and Patent Reform Whether through the courts or before Congress, the BlackBerry experience suggests that some modification of patent law is not only likely, it's necessary.
The Motley Fool April 26, 2005 Dave Mock	The Lowdown on Patent Shakedowns The business of extorting license fees for patents can be very lucrative -- and damaging. It is important for investors to understand how the companies they own utilize and protect their inventions -- and what approach management has taken to deal with intellectual property disputes.
Salon.com April 24, 2000 Mark Compton	Lean, green gene-counting machine Incyte CEO Roy Whitfield gives biotech investors and patent critics a few lessons on genomic research.